Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)

This study was performed to determine the activity of adding continuous infusion (CI) of 5-fluorouracil (5-FU) to gemcitabine (GEM) vs GEM alone in advanced pancreatic cancer (APC). In all, 94 chemo-naïve patients with APC were randomised to receive GEM alone (arm A: 1000 mg m(−2) per week for 7 wee...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Costanzo, F, Carlini, P, Doni, L, Massidda, B, Mattioli, R, Iop, A, Barletta, E, Moscetti, L, Recchia, F, Tralongo, P, Gasperoni, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361554/
https://www.ncbi.nlm.nih.gov/pubmed/15986036
http://dx.doi.org/10.1038/sj.bjc.6602640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361554/
https://www.ncbi.nlm.nih.gov/pubmed/15986036
http://dx.doi.org/10.1038/sj.bjc.6602640

Ejemplares similares